Adding camrelizumab and rivoceranib to TACE improved PFS in patients with unresectable HCC in a phase 2 trial.

Resolution of subjective symptoms was achieved in 63% of cases; AST diminished on average by 36%, ALT by 34% and GGT by 46%. Furthermore, the investigators reported a reduction in hepatomegaly ...

Adding camrelizumab and rivoceranib to transarterial chemoembolization (TACE) significantly prolonged progression-free ...

median 50 years, range: 18–77 years BMI: mean±SD: 25 ± 5 kg/m2, median: 25 kg/m2, range 17–36 kg/m2 AST: mean±SD: 42 ± 32 IU/L, median 31 IU/L, range: 21–207 IU/L ALT: mean±SD ...

The incidence of serious adverse events with tocilizumab was 3.8% versus 2.8% with methotrexate (p = 0.50), and of serious infections ... Increases in alanine aminotransferase (ALT)/aspartate ...

For the second day in a row, AST SpaceMobile (NASDAQ: ASTS) stock is hopping. And today? Today AST stock is flying 17.5% higher through 10:15 a.m. ET, and recouping all its losses from earlier in ...

AST SpaceMobile customer Vodafone completed the world's first DTC video phone call via satellite on Tuesday. Even astronauts agree that this is a "significant breakthrough." AST has not yet ...

The FCC has granted AST SpaceMobile Special Temporary Authorization to begin testing its satellites. AST has five BlueBird satellites in service, and will cooperate with AT&T and Verizon in the ...

MIDLAND, Texas--(BUSINESS WIRE)--AST SpaceMobile, Inc. (“AST SpaceMobile”) (NASDAQ: ASTS), the company building the first and only space-based cellular broadband network accessible directly by ...